These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22650028)

  • 21. [Correlation between interleukin-1 and the obesity of polycystic ovary syndrome].
    Yang Y; Qiao J; Li MZ
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):9-13. PubMed ID: 22455686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of metformin on the expression of GLUT4 in endometrium of obese women with polycystic ovary syndrome.
    Zhai J; Liu CX; Tian ZR; Jiang QH; Sun YP
    Biol Reprod; 2012 Aug; 87(2):29. PubMed ID: 22572996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased plasma visfatin concentrations in women with polycystic ovary syndrome.
    Chan TF; Chen YL; Chen HH; Lee CH; Jong SB; Tsai EM
    Fertil Steril; 2007 Aug; 88(2):401-5. PubMed ID: 17335820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress.
    Macut D; Simic T; Lissounov A; Pljesa-Ercegovac M; Bozic I; Djukic T; Bjekic-Macut J; Matic M; Petakov M; Suvakov S; Damjanovic S; Savic-Radojevic A
    Exp Clin Endocrinol Diabetes; 2011 Jul; 119(7):451-5. PubMed ID: 21667435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.
    Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y
    Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical significance and changes of serum visfatin, adiponectin and leptin levels in patients with polycystic ovarian syndrome].
    Wang Y; Yu P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 34(1):72-5. PubMed ID: 19197132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased adiponectin levels in polycystic ovary syndrome, independent of body mass index.
    Sharifi F; Hajihosseini R; Mazloomi S; Amirmogaddami H; Nazem H
    Metab Syndr Relat Disord; 2010 Feb; 8(1):47-52. PubMed ID: 19929617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma Visfatin Levels in Adolescents with Polycystic Ovary Syndrome: A Prospective Case-Control Study.
    Gümüş Ü; Güzel AI; Topcu HO; Timur H; Yılmaz N; Danışman N
    J Pediatr Adolesc Gynecol; 2015 Aug; 28(4):249-53. PubMed ID: 26049941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered.
    Torun AN; Vural M; Cece H; Camuzcuoglu H; Toy H; Aksoy N
    Gynecol Endocrinol; 2011 Dec; 27(12):988-92. PubMed ID: 21557696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between oxidative stress and the levels of serum circulating adhesion molecules in patients with hyperglycemia crises.
    Shen XP; Li J; Zou S; Wu HJ; Zhang Y
    J Diabetes Complications; 2012; 26(4):291-5. PubMed ID: 22658409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Peritoneal fluid leptin concentration and endocrine hormone in patients with polycystic ovarian syndrome].
    Xiao SS; Xue M; Deng XL; Wan YJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):786-91, 796. PubMed ID: 17062953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
    Svendsen PF; Nilas L; Nørgaard K; Jensen JE; Madsbad S
    Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular risk in adolescent and young adult obese females with polycystic ovary syndrome (PCOS).
    Macut D; Micić D; Cvijović G; Sumarac M; Kendereski A; Zorić S; Pejković D
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1353-59; discussion 1365. PubMed ID: 11964034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
    Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
    Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
    Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
    Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose intolerance in Japanese patients with polycystic ovary syndrome.
    Kurioka H; Takahashi K; Miyazaki K
    Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B; Mitkov M
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of leptin mRNA in luteinized granulosa cells and leptin levels in serum and follicular fluid of non-obese infertile patients with polycystic ovary syndrome].
    Lu XP; Wang B; Huang HF
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):88-91. PubMed ID: 15774212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.